Key result
Early diagnosis and prompt medical management of peripartum cardiomyopathy with standard heart failure therapies resulted in clinical improvement in two postpartum women.
Case Report (n=2)
No
Bromocriptine may be a potential therapeutic addition to standard therapy for peripartum cardiomyopathy by targeting elevated prolactin production.
Prompt standard therapy may aid peripartum cardiomyopathy recovery; leaves open bromocriptine adjunct role pending prospective trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shadi Rezai (2016) conducted a case report in Peripartum Cardiomyopathy (n=2). Standard heart failure medical therapy was evaluated on Clinical improvement and resolution of symptoms. Early diagnosis and prompt medical management of peripartum cardiomyopathy with standard heart failure therapies resulted in clinical improvement in two postpartum women.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: